# Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder

> **NCT00672568** · PHASE2 · TERMINATED · sponsor: **Anesiva, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Rotator Cuff Repair of the Shoulder

## Interventions

- **DRUG:** 4975 - Highly purified capsaicin
- **DRUG:** 4975 - Highly purified capsaicin
- **DRUG:** 4975 - Highly purified capsaicin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00672568
- **Lead sponsor:** Anesiva, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Study has been halted after completing Stage 1, for corporate reasons. No future patients will be enrolled or treated.
- **Last updated:** 2009-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672568, "Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00672568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*